bortezomib – Talk Bio

Actionable Insights Powered by AI

FDA Approves GSK’s Blenrep for Multiple Myeloma Treatment, Marking a Market Return

1 day ago talkbio0Tagged Approved, Blenrep, bortezomib, dexamethasone, Multiple Myeloma, SmithKline Beecham, United States Food and Drug Administration

Blenrep; GSK; FDA Approval; Multiple Myeloma; Bortezomib; Dexamethasone